JDRF supporter and leading researcher recognised with Order of Australia
Today, we are excited to announce that two important members of the JDRF community have been appointed members of the Order of Australia as part of the Queen’s Birthday 2021 Honours List.
We’re proud to be celebrating Helen Maxwell-Wright, Chair of our Victorian State Leadership Group and major supporter of type 1 diabetes research, for her dedication to improving the health and well-being outcomes of others. For over 10 years, Helen has dedicated herself to helping us achieve fundraising and advocacy goals. Helen’s leadership has made a significant impact on improving lives for the type 1 diabetes community.
We extend our heartfelt congratulations to Helen on receiving this well-deserved and hard-earned honour. You can read more about Helen and her achievements here.
Professor Patrick Toby Coates
Additionally, Professor Patrick Toby Coates, whose important research on islet transplantation is funded by JDRF, was recognised for his distinguished service to renal medicine, professional medical organisations and tertiary education. Toby leads a team of researchers at the Adelaide Medical School Centre for Clinical and Experimental Transplantation, which seeks innovative treatment and potential cures for type 1 diabetes.
Professor Coates’ recognition in the Queen’s Birthday Honours List is a credit to the calibre of type 1 diabetes researchers we have in Australia. We thank him for his ongoing work toward finding a cure for type 1 diabetes. You can read more about Professor Coates and his research here.
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, led […]
New research funding may allow those with type 1 diabetes to make insulin again
JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes ꟷ new funding announced.
JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]
Changes to the Federal Government’s Insulin Pump Program
The Australian Government’s Insulin Pump Program (IPP), administered by JDRF Australia, provides insulin pumps to young Australians up to the age of 21, living with type 1 diabetes (T1D), who meet certain financial and clinical eligibility requirements. The program supplies fully subsidised insulin pumps to people who would otherwise be unable to access insulin pump […]